InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: turks post# 11113

Friday, 01/13/2017 11:42:22 AM

Friday, January 13, 2017 11:42:22 AM

Post# of 16885
Pain trial press release won't come until Braeburn's offering closes. According to Braeburn's presentation at the JP Morgan Healthcare conference a year ago, approval for pain would double the expected annual sales of probuphine from $300 million to $600 million.

https://braeburnpharmaceuticals.com/wp-content/uploads/2016/01/Braeburn-Company-Overview-JPM-1.13-v2.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News